Huber Reid M Insider Trades

Insider Trading History

Track insider trading activity for Huber Reid M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $591k 15,200 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$535k 15,200 shares
$35.21
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $793k 20,400 shares
Last Trade
Sep 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$499k 20,400 shares
$24.48
$38.88
CARGO Therapeutics
CARGO Therapeutics CRGX
Director
Holding Value $0 0 shares
Last Trade
Aug 19, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$109k 25,000 shares
$4.35
$4.47
CARGO Therapeutics
CARGO Therapeutics CRGX
Director
Holding Value $112k 25,000 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 25,000 shares
$4.35
$4.47
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $850k 21,850 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 21,850 shares
$10.95
$38.88
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $852k 30,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 35,000 shares
$3.55
$28.39
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $11k 146,951 shares
Last Trade
Jan 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.2k 80,968 shares
$0.83
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $11.5k 153,179 shares
Last Trade
Jan 03, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.4k 87,196 shares
$0.83
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $4.94k 65,983 shares
Last Trade
Sep 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.6k 46,489 shares
$1.13
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $1.12k 15,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7k 15,000 shares
$1.11
$0.07
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $1.14M 40,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$236k 40,000 shares
$5.90
$28.39
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $0 0 shares
Last Trade
Jan 04, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.8k 19,494 shares
$1.53
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $1.46k 19,494 shares
Last Trade
Jan 04, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.8k 19,494 shares
$1.53
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $486 6,500 shares
Last Trade
Jun 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.8k 6,500 shares
$3.05
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $1.46k 19,494 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.3k 19,494 shares
$3.40
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $486 6,500 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.7k 6,500 shares
$8.42
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $1.87k 25,000 shares
Last Trade
Jun 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$490k 25,000 shares
$19.60
$0.07
Incyte
Incyte INCY
Evp, Chief Scientific Officer
Holding Value $3.61M 34,571 shares
Last Trade
Jul 16, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$31.4k 448 shares
$70.19
$104.40
Incyte
Incyte INCY
Evp, Chief Scientific Officer
Holding Value $3.66M 35,019 shares
Last Trade
Jul 05, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.4k 284 shares
$68.28
$104.40
Incyte
Incyte INCY
Evp, Chief Scientific Officer
Holding Value $2.38M 22,772 shares
Last Trade
Jul 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.56M 22,772 shares
$68.62
$104.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up